Table 6.
Agreement of medication details among those who reported use in both sources (n=50).
| Therapeutic Class | Women who reported in both† | Number of specific medications in both sources | Number of specific medications not in both sources | % agreement on specific medications |
|---|---|---|---|---|
| Antidiabetics | 5 | 9 | 5 | 64.3% |
| Antiemetics | 11 | 13 | 4 | 76.5% |
| Antiepileptics | 2 | 2 | 0 | 100.0% |
| Antihypertensives | 3 | 3 | 2 | 60.0% |
| Anti-infectives | 13 | 12 | 15 | 44.0% |
| Asthma medications | 2 | 2 | 0 | 100.0% |
| Fertility-related medications | 9 | 10 | 8 | 55.6% |
| Migraine medications | 2 | 1 | 2 | 33.3% |
| Opioid analgesics | 1 | 1 | 1 | 50.0% |
| Psychotherapeutics | 9 | 15 | 2 | 88.2% |
| Sleep aid medications | 2 | 0 | 4 | 0.0% |
| Thyroid medications | 8 | 8 | 0 | 100.0% |
†
The total number of specific medications in both sources and the number of medications not in both sources may not equal the number of women who reported both medications as women could report more than one medication within each therapeutic class.